IP Library Granted Patent US 7,176,010
Granted Patent B2
US 7,176,010 · App. 10/343,141 · Granted Feb 13, 2007

Isolated human protein having esterase activity and DNA encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,176,010
App. No.
10/343,141
Granted
Feb 13, 2007
Kind
B2
Abstract

The present invention provides novel esterase proteins, Specifically, the present invention provides proteins having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1 or SEQ ID NO: 7, or salts thereof; their partial peptides or salts thereof: DNAs encoding the proteins; recombinant vectors containing the DNAs; transformants, a method of manufacturing the proteins; pharmaceuticals comprising the proteins or DNAs; antibodies to the proteins; a method of screening compounds or salts thereof having an activity of promoting the esterase activity of the proteins; the compounds obtained by the screening; and pharmaceuticals comprising the said compounds; etc.

Claims (3)

1. An isolated protein or its salt, which consists of the amino acid sequence of SEQ ID NO: 1, having triglyceride degradation activity.

2. A method of screening a compound or its salt that promotes or inhibits the triglyceride degradation activity of the protein according to claim 1 or salt thereof, which comprises (i) contacting the protein of claim 1 or salt thereof, with a test compound (ii) detecting triglyceride degradation activity and comparing said activity with that measured in the absence of the test compound, and (iii) determining if said test compound inhibits or promotes triglyceride degradation activity.

3. A kit for screening a compound or its salt that promotes or inhibits the triglyceride degradation activity of the protein according to claim 1 or salt thereof, comprising the protein according to claim 1 or salt thereof.

Assignments (2)
CHANGE OF NAME Recorded Jun 17, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016914/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2003
From: TOZAWA, RYUICHI; SUNAHARA, EIJI; TANIYAMA, YOSHIO
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 014111/0783 →